[go: up one dir, main page]

Kidney Diseases

"Kidney Diseases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

expand / collapse MeSH information


expand / collapse Publications
This graph shows the total number of publications written about "Kidney Diseases" by people in this website by year, and whether "Kidney Diseases" was a major or minor topic of these publications.
Below are the most recent publications written about "Kidney Diseases" by people in Profiles.
  1. Norwegian kidney biopsy biobank (NorKiBB): organization, baseline characteristics, and generalizability of a low-cost national biobank. BMC Nephrol. 2025 Feb 13; 26(1):76.
    View in: PubMed
  2. Kidney multiome-based genetic scorecard reveals convergent coding and regulatory variants. Science. 2025 Feb 07; 387(6734):eadp4753.
    View in: PubMed
  3. Use of Potentially Nephrotoxic Drugs in Type 2 Diabetes Patients on SGLT2i: A Trajectories Analysis. Pharmacoepidemiol Drug Saf. 2025 Feb; 34(2):e70098.
    View in: PubMed
  4. Successful use of deceased donors with medically complex kidneys. Transplant Rev (Orlando). 2025 Jan; 39(1):100888.
    View in: PubMed
  5. A kidney-specific fasting-mimicking diet induces podocyte reprogramming and restores renal function in glomerulopathy. Sci Transl Med. 2024 Oct 30; 16(771):eadl5514.
    View in: PubMed
  6. Effects of high-fat diet on folic acid-induced kidney injury in mice. Biochim Biophys Acta Mol Cell Res. 2024 Dec; 1871(8):119856.
    View in: PubMed
  7. Evaluation and Management of Kidney Dysfunction in Advanced Heart Failure: A Scientific Statement From the American Heart Association. Circulation. 2024 Oct 15; 150(16):e280-e295.
    View in: PubMed
  8. Increased risk of kidney failure in patients with genetic kidney disorders. J Clin Invest. 2024 Sep 03; 134(17).
    View in: PubMed
  9. A randomized, placebo-controlled, dose-escalation phase I/II multicenter trial of low-dose cidofovir for BK polyomavirus nephropathy. Transpl Infect Dis. 2024 Dec; 26(6):e14367.
    View in: PubMed
  10. See the power in kidney cells with ATP biosensor. Kidney Int. 2024 Sep; 106(3):362-364.
    View in: PubMed